The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in atrophic AMD.
Ghosh S, Sharma R, Bammidi S, Koontz V, Nemani M, Yazdankhah M, Kedziora KM, Wallace CT, Yu-Wei C, Franks J, Bose D, Rajasundaram D, Hose S, Sahel JA, Puertollano R, Finkel T, Zigler JS, Sergeev Y, Watkins SC, Goetzman ES, Flores-Bellver M, Kaarniranta K, Sodhi A, Bharti K, Handa JT, Sinha D.
Ghosh S, et al. Among authors: hose s.
bioRxiv [Preprint]. 2023 Aug 9:2023.08.08.552343. doi: 10.1101/2023.08.08.552343.
bioRxiv. 2023.
PMID: 37609254
Free PMC article.
Preprint.